Review



osteoclast differentiation  (TaKaRa)


Bioz Verified Symbol TaKaRa is a verified supplier
Bioz Manufacturer Symbol TaKaRa manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    TaKaRa osteoclast differentiation
    (A) A pictographic illustration of the workflow for this experiment, created in BioRender. Green, R. (2025) https://BioRender.com/seaeapz . Osteoclasts derived from Human PBMCs were grown on bone chips in osteoclastogenic media for 14 days with media collected at day 12 and cells were fixed and stained for TRAP at day 14. Media treatments included GALT model media (Vehicle), media control-treated GALT-conditioned basolateral media (GALT), or apical SBD111-treated GALT-conditioned basolateral media (MOI 10). Following fixation, cells were stained for TRAP and quantified using NOISe. ( B ) Representative images of TRAP+ osteoclasts grown on bone chips illustrating effects of treated media. ( C ) Example of NOISe quantification and segmentation abilities. ( D ) NOISe-based quantification of <t>osteoclast</t> number and ( E ) TRAP+ area. ( F ) CTX-1 levels (a soluble measure of resorbed bone) were measured by ELISA in media collected from the osteoclast culture 12 days post isolation. Bars indicate mean and SEM based on n = 3 for count and area measures ( D, E ). Boxplots represent median and interquartile range, with whiskers representing max and min values, of n = 4 independent experiments for bone resorption ( F ). Vehicle condition is shown to display the normal range of human PBMC-derived osteoclast resorption and differentiation measures. Significance between conditions was determined by one-way ANOVA with Tukey’s HSD and significant p values ( p < 0.05) are included presented.
    Osteoclast Differentiation, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 251 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/osteoclast differentiation/product/TaKaRa
    Average 96 stars, based on 251 article reviews
    osteoclast differentiation - by Bioz Stars, 2026-02
    96/100 stars

    Images

    1) Product Images from "A synbiotic medical food improves gut barrier function, reduces immune responses, and inhibits osteoclast activity in models of postmenopausal bone loss aligned with clinical outcomes"

    Article Title: A synbiotic medical food improves gut barrier function, reduces immune responses, and inhibits osteoclast activity in models of postmenopausal bone loss aligned with clinical outcomes

    Journal: Journal of functional foods

    doi: 10.1016/j.jff.2025.107114

    (A) A pictographic illustration of the workflow for this experiment, created in BioRender. Green, R. (2025) https://BioRender.com/seaeapz . Osteoclasts derived from Human PBMCs were grown on bone chips in osteoclastogenic media for 14 days with media collected at day 12 and cells were fixed and stained for TRAP at day 14. Media treatments included GALT model media (Vehicle), media control-treated GALT-conditioned basolateral media (GALT), or apical SBD111-treated GALT-conditioned basolateral media (MOI 10). Following fixation, cells were stained for TRAP and quantified using NOISe. ( B ) Representative images of TRAP+ osteoclasts grown on bone chips illustrating effects of treated media. ( C ) Example of NOISe quantification and segmentation abilities. ( D ) NOISe-based quantification of osteoclast number and ( E ) TRAP+ area. ( F ) CTX-1 levels (a soluble measure of resorbed bone) were measured by ELISA in media collected from the osteoclast culture 12 days post isolation. Bars indicate mean and SEM based on n = 3 for count and area measures ( D, E ). Boxplots represent median and interquartile range, with whiskers representing max and min values, of n = 4 independent experiments for bone resorption ( F ). Vehicle condition is shown to display the normal range of human PBMC-derived osteoclast resorption and differentiation measures. Significance between conditions was determined by one-way ANOVA with Tukey’s HSD and significant p values ( p < 0.05) are included presented.
    Figure Legend Snippet: (A) A pictographic illustration of the workflow for this experiment, created in BioRender. Green, R. (2025) https://BioRender.com/seaeapz . Osteoclasts derived from Human PBMCs were grown on bone chips in osteoclastogenic media for 14 days with media collected at day 12 and cells were fixed and stained for TRAP at day 14. Media treatments included GALT model media (Vehicle), media control-treated GALT-conditioned basolateral media (GALT), or apical SBD111-treated GALT-conditioned basolateral media (MOI 10). Following fixation, cells were stained for TRAP and quantified using NOISe. ( B ) Representative images of TRAP+ osteoclasts grown on bone chips illustrating effects of treated media. ( C ) Example of NOISe quantification and segmentation abilities. ( D ) NOISe-based quantification of osteoclast number and ( E ) TRAP+ area. ( F ) CTX-1 levels (a soluble measure of resorbed bone) were measured by ELISA in media collected from the osteoclast culture 12 days post isolation. Bars indicate mean and SEM based on n = 3 for count and area measures ( D, E ). Boxplots represent median and interquartile range, with whiskers representing max and min values, of n = 4 independent experiments for bone resorption ( F ). Vehicle condition is shown to display the normal range of human PBMC-derived osteoclast resorption and differentiation measures. Significance between conditions was determined by one-way ANOVA with Tukey’s HSD and significant p values ( p < 0.05) are included presented.

    Techniques Used: Derivative Assay, Staining, Control, Enzyme-linked Immunosorbent Assay, Isolation

    Impaired intestinal barrier integrity, as occurs during aging, obesity, and the menopause transition permits translocation of inflammatory microbial components into intestinal tissues. This activates the epithelium and local immune cells which further compromise barrier integrity, allowing translocation of additional inflammatory components. This cycle promotes systemic inflammation and promotes osteoclastogenesis and bone resorption through the migration of osteoclast-activating inflammatory immune cells and diffusion of osteoclast-modulating compounds to bone. SBD111 disrupts this cycle by enhancing intestinal barrier integrity and, in the case of disrupted barriers, by reducing inflammatory mediator secretion (T cell polarizing and neutrophil chemoattractant) by inflamed immune cells. Furthermore, SBD111 has shown the potential to produce an anti-osteoclastogenic environment through interactions with intestinal epithelial cells and underlying immune cells. Together these mechanisms may contribute to the bone-protective effects of SBD111 observed in groups of postmenopausal women. Image created in https://BioRender.com . Green, R. (2025) https://BioRender.com/sty1qzs .
    Figure Legend Snippet: Impaired intestinal barrier integrity, as occurs during aging, obesity, and the menopause transition permits translocation of inflammatory microbial components into intestinal tissues. This activates the epithelium and local immune cells which further compromise barrier integrity, allowing translocation of additional inflammatory components. This cycle promotes systemic inflammation and promotes osteoclastogenesis and bone resorption through the migration of osteoclast-activating inflammatory immune cells and diffusion of osteoclast-modulating compounds to bone. SBD111 disrupts this cycle by enhancing intestinal barrier integrity and, in the case of disrupted barriers, by reducing inflammatory mediator secretion (T cell polarizing and neutrophil chemoattractant) by inflamed immune cells. Furthermore, SBD111 has shown the potential to produce an anti-osteoclastogenic environment through interactions with intestinal epithelial cells and underlying immune cells. Together these mechanisms may contribute to the bone-protective effects of SBD111 observed in groups of postmenopausal women. Image created in https://BioRender.com . Green, R. (2025) https://BioRender.com/sty1qzs .

    Techniques Used: Translocation Assay, Migration, Diffusion-based Assay



    Similar Products

    99
    ATCC osteoclast differentiation assay raw264 7 cells
    Osteoclast Differentiation Assay Raw264 7 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/osteoclast differentiation assay raw264 7 cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    osteoclast differentiation assay raw264 7 cells - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    96
    TaKaRa osteoclast differentiation
    (A) A pictographic illustration of the workflow for this experiment, created in BioRender. Green, R. (2025) https://BioRender.com/seaeapz . Osteoclasts derived from Human PBMCs were grown on bone chips in osteoclastogenic media for 14 days with media collected at day 12 and cells were fixed and stained for TRAP at day 14. Media treatments included GALT model media (Vehicle), media control-treated GALT-conditioned basolateral media (GALT), or apical SBD111-treated GALT-conditioned basolateral media (MOI 10). Following fixation, cells were stained for TRAP and quantified using NOISe. ( B ) Representative images of TRAP+ osteoclasts grown on bone chips illustrating effects of treated media. ( C ) Example of NOISe quantification and segmentation abilities. ( D ) NOISe-based quantification of <t>osteoclast</t> number and ( E ) TRAP+ area. ( F ) CTX-1 levels (a soluble measure of resorbed bone) were measured by ELISA in media collected from the osteoclast culture 12 days post isolation. Bars indicate mean and SEM based on n = 3 for count and area measures ( D, E ). Boxplots represent median and interquartile range, with whiskers representing max and min values, of n = 4 independent experiments for bone resorption ( F ). Vehicle condition is shown to display the normal range of human PBMC-derived osteoclast resorption and differentiation measures. Significance between conditions was determined by one-way ANOVA with Tukey’s HSD and significant p values ( p < 0.05) are included presented.
    Osteoclast Differentiation, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/osteoclast differentiation/product/TaKaRa
    Average 96 stars, based on 1 article reviews
    osteoclast differentiation - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology primary antibodies against osteoclast differentiation markers
    (A) A pictographic illustration of the workflow for this experiment, created in BioRender. Green, R. (2025) https://BioRender.com/seaeapz . Osteoclasts derived from Human PBMCs were grown on bone chips in osteoclastogenic media for 14 days with media collected at day 12 and cells were fixed and stained for TRAP at day 14. Media treatments included GALT model media (Vehicle), media control-treated GALT-conditioned basolateral media (GALT), or apical SBD111-treated GALT-conditioned basolateral media (MOI 10). Following fixation, cells were stained for TRAP and quantified using NOISe. ( B ) Representative images of TRAP+ osteoclasts grown on bone chips illustrating effects of treated media. ( C ) Example of NOISe quantification and segmentation abilities. ( D ) NOISe-based quantification of <t>osteoclast</t> number and ( E ) TRAP+ area. ( F ) CTX-1 levels (a soluble measure of resorbed bone) were measured by ELISA in media collected from the osteoclast culture 12 days post isolation. Bars indicate mean and SEM based on n = 3 for count and area measures ( D, E ). Boxplots represent median and interquartile range, with whiskers representing max and min values, of n = 4 independent experiments for bone resorption ( F ). Vehicle condition is shown to display the normal range of human PBMC-derived osteoclast resorption and differentiation measures. Significance between conditions was determined by one-way ANOVA with Tukey’s HSD and significant p values ( p < 0.05) are included presented.
    Primary Antibodies Against Osteoclast Differentiation Markers, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against osteoclast differentiation markers/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    primary antibodies against osteoclast differentiation markers - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    95
    R&D Systems osteoclastic differentiation induction via rankl
    ( A ) Representative cytochemical tartrate-resistant acid phosphatase (TRAP) staining images, Scale bar, 200 um. ( B ) The amounts of osteoclasts (multinucleated TRAP-positive cells), n = 5. ( C ) The positive TRAP area of osteoclasts, n = 5. ( D ) Representative resorption pits, Scale bar, 200 um. ( E ) The area of resorbed surface, n = 6. ( F ) qRT-PCR quantification analysis of Acp5 , Nfatc1 , Mmp9 expression of <t>RANKL-induced</t> RAW264.7 transfected with mimic-NC, mimic-miR-335-3p, inhibitor-NC, or inhibitor-miR-335-3p, n = 3. ( G ) Representative IF images for FOS, NFATC1, and HOCHEST expression, Scale bar, 200 um. ( H ) Three-dimensional reconstruction images of femurs from agomir NC, agomir-mir-335-3p, antagomir NC, and antagomir-miR-335-3p mice. ( I ) Quantitative micro-CT analysis of femur trabecular bone, n = 3; scale bar, 1 mm. All data are presented as mean ± SD; *p<0.05, **p<0.01, ***p<0.001, by unpaired Student’s t -test. Figure 5—source data 1. Full dataset for .
    Osteoclastic Differentiation Induction Via Rankl, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/osteoclastic differentiation induction via rankl/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    osteoclastic differentiation induction via rankl - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    99
    Miltenyi Biotec human osteoclast differentiation cd14 monocytes
    ( A ) Representative cytochemical tartrate-resistant acid phosphatase (TRAP) staining images, Scale bar, 200 um. ( B ) The amounts of osteoclasts (multinucleated TRAP-positive cells), n = 5. ( C ) The positive TRAP area of osteoclasts, n = 5. ( D ) Representative resorption pits, Scale bar, 200 um. ( E ) The area of resorbed surface, n = 6. ( F ) qRT-PCR quantification analysis of Acp5 , Nfatc1 , Mmp9 expression of <t>RANKL-induced</t> RAW264.7 transfected with mimic-NC, mimic-miR-335-3p, inhibitor-NC, or inhibitor-miR-335-3p, n = 3. ( G ) Representative IF images for FOS, NFATC1, and HOCHEST expression, Scale bar, 200 um. ( H ) Three-dimensional reconstruction images of femurs from agomir NC, agomir-mir-335-3p, antagomir NC, and antagomir-miR-335-3p mice. ( I ) Quantitative micro-CT analysis of femur trabecular bone, n = 3; scale bar, 1 mm. All data are presented as mean ± SD; *p<0.05, **p<0.01, ***p<0.001, by unpaired Student’s t -test. Figure 5—source data 1. Full dataset for .
    Human Osteoclast Differentiation Cd14 Monocytes, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human osteoclast differentiation cd14 monocytes/product/Miltenyi Biotec
    Average 99 stars, based on 1 article reviews
    human osteoclast differentiation cd14 monocytes - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    94
    MedChemExpress osteoclast differentiation
    ( A ) Representative cytochemical tartrate-resistant acid phosphatase (TRAP) staining images, Scale bar, 200 um. ( B ) The amounts of osteoclasts (multinucleated TRAP-positive cells), n = 5. ( C ) The positive TRAP area of osteoclasts, n = 5. ( D ) Representative resorption pits, Scale bar, 200 um. ( E ) The area of resorbed surface, n = 6. ( F ) qRT-PCR quantification analysis of Acp5 , Nfatc1 , Mmp9 expression of <t>RANKL-induced</t> RAW264.7 transfected with mimic-NC, mimic-miR-335-3p, inhibitor-NC, or inhibitor-miR-335-3p, n = 3. ( G ) Representative IF images for FOS, NFATC1, and HOCHEST expression, Scale bar, 200 um. ( H ) Three-dimensional reconstruction images of femurs from agomir NC, agomir-mir-335-3p, antagomir NC, and antagomir-miR-335-3p mice. ( I ) Quantitative micro-CT analysis of femur trabecular bone, n = 3; scale bar, 1 mm. All data are presented as mean ± SD; *p<0.05, **p<0.01, ***p<0.001, by unpaired Student’s t -test. Figure 5—source data 1. Full dataset for .
    Osteoclast Differentiation, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/osteoclast differentiation/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    osteoclast differentiation - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    R&D Systems osteoclastic differentiation marker
    ( A ) Representative cytochemical tartrate-resistant acid phosphatase (TRAP) staining images, Scale bar, 200 um. ( B ) The amounts of osteoclasts (multinucleated TRAP-positive cells), n = 5. ( C ) The positive TRAP area of osteoclasts, n = 5. ( D ) Representative resorption pits, Scale bar, 200 um. ( E ) The area of resorbed surface, n = 6. ( F ) qRT-PCR quantification analysis of Acp5 , Nfatc1 , Mmp9 expression of <t>RANKL-induced</t> RAW264.7 transfected with mimic-NC, mimic-miR-335-3p, inhibitor-NC, or inhibitor-miR-335-3p, n = 3. ( G ) Representative IF images for FOS, NFATC1, and HOCHEST expression, Scale bar, 200 um. ( H ) Three-dimensional reconstruction images of femurs from agomir NC, agomir-mir-335-3p, antagomir NC, and antagomir-miR-335-3p mice. ( I ) Quantitative micro-CT analysis of femur trabecular bone, n = 3; scale bar, 1 mm. All data are presented as mean ± SD; *p<0.05, **p<0.01, ***p<0.001, by unpaired Student’s t -test. Figure 5—source data 1. Full dataset for .
    Osteoclastic Differentiation Marker, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/osteoclastic differentiation marker/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    osteoclastic differentiation marker - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Selleck Chemicals activin a mediated osteoclast differentiation
    ( A ) Representative cytochemical tartrate-resistant acid phosphatase (TRAP) staining images, Scale bar, 200 um. ( B ) The amounts of osteoclasts (multinucleated TRAP-positive cells), n = 5. ( C ) The positive TRAP area of osteoclasts, n = 5. ( D ) Representative resorption pits, Scale bar, 200 um. ( E ) The area of resorbed surface, n = 6. ( F ) qRT-PCR quantification analysis of Acp5 , Nfatc1 , Mmp9 expression of <t>RANKL-induced</t> RAW264.7 transfected with mimic-NC, mimic-miR-335-3p, inhibitor-NC, or inhibitor-miR-335-3p, n = 3. ( G ) Representative IF images for FOS, NFATC1, and HOCHEST expression, Scale bar, 200 um. ( H ) Three-dimensional reconstruction images of femurs from agomir NC, agomir-mir-335-3p, antagomir NC, and antagomir-miR-335-3p mice. ( I ) Quantitative micro-CT analysis of femur trabecular bone, n = 3; scale bar, 1 mm. All data are presented as mean ± SD; *p<0.05, **p<0.01, ***p<0.001, by unpaired Student’s t -test. Figure 5—source data 1. Full dataset for .
    Activin A Mediated Osteoclast Differentiation, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/activin a mediated osteoclast differentiation/product/Selleck Chemicals
    Average 94 stars, based on 1 article reviews
    activin a mediated osteoclast differentiation - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A) A pictographic illustration of the workflow for this experiment, created in BioRender. Green, R. (2025) https://BioRender.com/seaeapz . Osteoclasts derived from Human PBMCs were grown on bone chips in osteoclastogenic media for 14 days with media collected at day 12 and cells were fixed and stained for TRAP at day 14. Media treatments included GALT model media (Vehicle), media control-treated GALT-conditioned basolateral media (GALT), or apical SBD111-treated GALT-conditioned basolateral media (MOI 10). Following fixation, cells were stained for TRAP and quantified using NOISe. ( B ) Representative images of TRAP+ osteoclasts grown on bone chips illustrating effects of treated media. ( C ) Example of NOISe quantification and segmentation abilities. ( D ) NOISe-based quantification of osteoclast number and ( E ) TRAP+ area. ( F ) CTX-1 levels (a soluble measure of resorbed bone) were measured by ELISA in media collected from the osteoclast culture 12 days post isolation. Bars indicate mean and SEM based on n = 3 for count and area measures ( D, E ). Boxplots represent median and interquartile range, with whiskers representing max and min values, of n = 4 independent experiments for bone resorption ( F ). Vehicle condition is shown to display the normal range of human PBMC-derived osteoclast resorption and differentiation measures. Significance between conditions was determined by one-way ANOVA with Tukey’s HSD and significant p values ( p < 0.05) are included presented.

    Journal: Journal of functional foods

    Article Title: A synbiotic medical food improves gut barrier function, reduces immune responses, and inhibits osteoclast activity in models of postmenopausal bone loss aligned with clinical outcomes

    doi: 10.1016/j.jff.2025.107114

    Figure Lengend Snippet: (A) A pictographic illustration of the workflow for this experiment, created in BioRender. Green, R. (2025) https://BioRender.com/seaeapz . Osteoclasts derived from Human PBMCs were grown on bone chips in osteoclastogenic media for 14 days with media collected at day 12 and cells were fixed and stained for TRAP at day 14. Media treatments included GALT model media (Vehicle), media control-treated GALT-conditioned basolateral media (GALT), or apical SBD111-treated GALT-conditioned basolateral media (MOI 10). Following fixation, cells were stained for TRAP and quantified using NOISe. ( B ) Representative images of TRAP+ osteoclasts grown on bone chips illustrating effects of treated media. ( C ) Example of NOISe quantification and segmentation abilities. ( D ) NOISe-based quantification of osteoclast number and ( E ) TRAP+ area. ( F ) CTX-1 levels (a soluble measure of resorbed bone) were measured by ELISA in media collected from the osteoclast culture 12 days post isolation. Bars indicate mean and SEM based on n = 3 for count and area measures ( D, E ). Boxplots represent median and interquartile range, with whiskers representing max and min values, of n = 4 independent experiments for bone resorption ( F ). Vehicle condition is shown to display the normal range of human PBMC-derived osteoclast resorption and differentiation measures. Significance between conditions was determined by one-way ANOVA with Tukey’s HSD and significant p values ( p < 0.05) are included presented.

    Article Snippet: Cells were analyzed for tartrate-resistant acid phosphatase (TRAP) activity to quantify osteoclast differentiation as per manufacturer’s instructions (CAT# MK301, Takara; San Jose, CA).

    Techniques: Derivative Assay, Staining, Control, Enzyme-linked Immunosorbent Assay, Isolation

    Impaired intestinal barrier integrity, as occurs during aging, obesity, and the menopause transition permits translocation of inflammatory microbial components into intestinal tissues. This activates the epithelium and local immune cells which further compromise barrier integrity, allowing translocation of additional inflammatory components. This cycle promotes systemic inflammation and promotes osteoclastogenesis and bone resorption through the migration of osteoclast-activating inflammatory immune cells and diffusion of osteoclast-modulating compounds to bone. SBD111 disrupts this cycle by enhancing intestinal barrier integrity and, in the case of disrupted barriers, by reducing inflammatory mediator secretion (T cell polarizing and neutrophil chemoattractant) by inflamed immune cells. Furthermore, SBD111 has shown the potential to produce an anti-osteoclastogenic environment through interactions with intestinal epithelial cells and underlying immune cells. Together these mechanisms may contribute to the bone-protective effects of SBD111 observed in groups of postmenopausal women. Image created in https://BioRender.com . Green, R. (2025) https://BioRender.com/sty1qzs .

    Journal: Journal of functional foods

    Article Title: A synbiotic medical food improves gut barrier function, reduces immune responses, and inhibits osteoclast activity in models of postmenopausal bone loss aligned with clinical outcomes

    doi: 10.1016/j.jff.2025.107114

    Figure Lengend Snippet: Impaired intestinal barrier integrity, as occurs during aging, obesity, and the menopause transition permits translocation of inflammatory microbial components into intestinal tissues. This activates the epithelium and local immune cells which further compromise barrier integrity, allowing translocation of additional inflammatory components. This cycle promotes systemic inflammation and promotes osteoclastogenesis and bone resorption through the migration of osteoclast-activating inflammatory immune cells and diffusion of osteoclast-modulating compounds to bone. SBD111 disrupts this cycle by enhancing intestinal barrier integrity and, in the case of disrupted barriers, by reducing inflammatory mediator secretion (T cell polarizing and neutrophil chemoattractant) by inflamed immune cells. Furthermore, SBD111 has shown the potential to produce an anti-osteoclastogenic environment through interactions with intestinal epithelial cells and underlying immune cells. Together these mechanisms may contribute to the bone-protective effects of SBD111 observed in groups of postmenopausal women. Image created in https://BioRender.com . Green, R. (2025) https://BioRender.com/sty1qzs .

    Article Snippet: Cells were analyzed for tartrate-resistant acid phosphatase (TRAP) activity to quantify osteoclast differentiation as per manufacturer’s instructions (CAT# MK301, Takara; San Jose, CA).

    Techniques: Translocation Assay, Migration, Diffusion-based Assay

    ( A ) Representative cytochemical tartrate-resistant acid phosphatase (TRAP) staining images, Scale bar, 200 um. ( B ) The amounts of osteoclasts (multinucleated TRAP-positive cells), n = 5. ( C ) The positive TRAP area of osteoclasts, n = 5. ( D ) Representative resorption pits, Scale bar, 200 um. ( E ) The area of resorbed surface, n = 6. ( F ) qRT-PCR quantification analysis of Acp5 , Nfatc1 , Mmp9 expression of RANKL-induced RAW264.7 transfected with mimic-NC, mimic-miR-335-3p, inhibitor-NC, or inhibitor-miR-335-3p, n = 3. ( G ) Representative IF images for FOS, NFATC1, and HOCHEST expression, Scale bar, 200 um. ( H ) Three-dimensional reconstruction images of femurs from agomir NC, agomir-mir-335-3p, antagomir NC, and antagomir-miR-335-3p mice. ( I ) Quantitative micro-CT analysis of femur trabecular bone, n = 3; scale bar, 1 mm. All data are presented as mean ± SD; *p<0.05, **p<0.01, ***p<0.001, by unpaired Student’s t -test. Figure 5—source data 1. Full dataset for .

    Journal: eLife

    Article Title: Psychological stress disturbs bone metabolism via miR-335-3p/Fos signaling in osteoclast

    doi: 10.7554/eLife.95944

    Figure Lengend Snippet: ( A ) Representative cytochemical tartrate-resistant acid phosphatase (TRAP) staining images, Scale bar, 200 um. ( B ) The amounts of osteoclasts (multinucleated TRAP-positive cells), n = 5. ( C ) The positive TRAP area of osteoclasts, n = 5. ( D ) Representative resorption pits, Scale bar, 200 um. ( E ) The area of resorbed surface, n = 6. ( F ) qRT-PCR quantification analysis of Acp5 , Nfatc1 , Mmp9 expression of RANKL-induced RAW264.7 transfected with mimic-NC, mimic-miR-335-3p, inhibitor-NC, or inhibitor-miR-335-3p, n = 3. ( G ) Representative IF images for FOS, NFATC1, and HOCHEST expression, Scale bar, 200 um. ( H ) Three-dimensional reconstruction images of femurs from agomir NC, agomir-mir-335-3p, antagomir NC, and antagomir-miR-335-3p mice. ( I ) Quantitative micro-CT analysis of femur trabecular bone, n = 3; scale bar, 1 mm. All data are presented as mean ± SD; *p<0.05, **p<0.01, ***p<0.001, by unpaired Student’s t -test. Figure 5—source data 1. Full dataset for .

    Article Snippet: They were used for osteoclastic differentiation induction via RANKL (R&D Systems, USA; 462-TEC) (50 nM).

    Techniques: Staining, Quantitative RT-PCR, Expressing, Transfection, Micro-CT

    ( A ) The ingenuity pathways analysis (IPA) of miR-335-3p and its predictive target gene. ( B ) Kyoto Encyclopedia of Genes and Genomes (KEGG) terms associated with targeted mRNA of differentially expressed miRNAs between groups obtained by database (miRDB and miRTarBase) prediction. ( D ) Firefly luciferase activity (n = 3). ( C ) Sequence alignment of miR-335-3p and its predictive target sites in 3′UTR of Fos . ( E ) Representative IF images for FOS, CTSK, and HOCHEST expression in the femur (scale bar, 50 um). ( F ) Representative cytochemical tartrate-resistant acid phosphatase (TRAP) staining images (scale bar, 200 um). ( G ) The area and ( H ) the number of osteoclasts (multinucleated TRAP-positive cells) (n = 4). ( I ) qRT-PCR quantification analysis of Acp5 , Nfatc1 , Mmp9 expression of RANKL-induced RAW264.7 transfected with inhibitor-NC, miR-335-3p-inhibitor, or miR-335-3p-inhibitor+T5224 (n = 3).All data are presented as mean ± SD; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, by one-way ANOVA with Tukey’s post hoc test. Figure 6—source data 1. Full dataset for .

    Journal: eLife

    Article Title: Psychological stress disturbs bone metabolism via miR-335-3p/Fos signaling in osteoclast

    doi: 10.7554/eLife.95944

    Figure Lengend Snippet: ( A ) The ingenuity pathways analysis (IPA) of miR-335-3p and its predictive target gene. ( B ) Kyoto Encyclopedia of Genes and Genomes (KEGG) terms associated with targeted mRNA of differentially expressed miRNAs between groups obtained by database (miRDB and miRTarBase) prediction. ( D ) Firefly luciferase activity (n = 3). ( C ) Sequence alignment of miR-335-3p and its predictive target sites in 3′UTR of Fos . ( E ) Representative IF images for FOS, CTSK, and HOCHEST expression in the femur (scale bar, 50 um). ( F ) Representative cytochemical tartrate-resistant acid phosphatase (TRAP) staining images (scale bar, 200 um). ( G ) The area and ( H ) the number of osteoclasts (multinucleated TRAP-positive cells) (n = 4). ( I ) qRT-PCR quantification analysis of Acp5 , Nfatc1 , Mmp9 expression of RANKL-induced RAW264.7 transfected with inhibitor-NC, miR-335-3p-inhibitor, or miR-335-3p-inhibitor+T5224 (n = 3).All data are presented as mean ± SD; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, by one-way ANOVA with Tukey’s post hoc test. Figure 6—source data 1. Full dataset for .

    Article Snippet: They were used for osteoclastic differentiation induction via RANKL (R&D Systems, USA; 462-TEC) (50 nM).

    Techniques: Luciferase, Activity Assay, Sequencing, Expressing, Staining, Quantitative RT-PCR, Transfection

    Journal: eLife

    Article Title: Psychological stress disturbs bone metabolism via miR-335-3p/Fos signaling in osteoclast

    doi: 10.7554/eLife.95944

    Figure Lengend Snippet:

    Article Snippet: They were used for osteoclastic differentiation induction via RANKL (R&D Systems, USA; 462-TEC) (50 nM).

    Techniques: